Colorado Code
Part 1 - General Provisions
§ 12-280-103. Definitions - Rules

As used in this article 280, unless the context otherwise requires or the term is otherwise defined in another part of this article 280:







(8.5) "Certification" means a certification to practice as a pharmacy technician issued by the board in accordance with section 12-280-115.5 (2) and includes a provisional certification issued in accordance with section 12-280-115.5 (3).
(8.7) "Certifying organization" means a board-approved, nationally recognized organization that certifies pharmacy technicians.

(9.5) "Chronic maintenance drug" means a drug that:


(9.7) "Community mental health clinic" has the same meaning as set forth in section 25-27.6-102 (9).










(15.5) "DQSA" means the federal "Drug Quality and Security Act", Pub.L. 113-54, as amended.



























(28.5) "Nonresident 503B outsourcing facility" means a facility that is registered by the FDA, that is located outside the state, and that distributes compounded drugs into the state without a prescription order.
















(35.5) "Pharmacist care services" means patient care activities provided by a pharmacist, with or without dispensing a drug, that are intended to achieve outcomes related to curing or preventing disease, eliminating or reducing a patient's symptoms, or arresting or slowing the process of a disease. "Pharmacist care services" includes efforts to prevent, detect, and resolve medication-related problems.






















































(46.5) "Resident 503B outsourcing facility" means a facility that is registered by the FDA, that is located in the state, and that distributes compounded drugs within the state.




(I) Is registered as an other outlet under this article 280;
(II) At the time of registration, is located more than twenty miles from the nearest prescription drug outlet and from any other telepharmacy outlet registered under this article 280;




(52.5) "Third-party logistics provider" means a person that contracts with a manufacturer to provide or coordinate warehousing, distribution, or other services on behalf of a manufacturer but does not take title to a prescription drug or have general responsibility to direct the prescription drug's sale or disposition.






















Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1435, § 1, effective October 1; (8.5), (8.7), and (38.5) added and (38), (49), and (50)(a)(IV) amended, (HB 19-1242), ch. 434, p. 3747, § 1, effective October 1; (9.5) and (39)(d) added and (39)(b)(III) and (39)(c)(II)(C) amended, (HB 19-1077), ch. 40, p. 137, § 4, effective October 1; IP(32)(b) amended, (HB 19-1109), ch. 23, p. 80, § 2, effective October 1. L. 2020: (7) amended, (HB 20-1402), ch. 216, p. 1045, § 22, effective June 30; (39)(c)(II)(C) amended, (HB 20-1216), ch. 190, p. 881, § 30, effective July 1; (39)(c)(II)(C) and (39)(d) amended and (39)(e) added, (HB 20-1061), ch. 281, p. 1375, § 4, effective July 13; (8) amended, (HB 20-1050), ch. 76, p. 313, § 1, effective September 14; IP(32)(a) amended, (SB 20-136), ch. 70, p. 287, § 20, effective September 14. L. 2021: (3), (4), (27), IP(32)(a), (38.5)(a)(V), (38.5)(a)(VI), (39)(a), (39)(d), (40), (43), (48), (54)(b)(III), (54)(b)(XI), and (55) amended, (9), (34), (37), (54)(b)(IX), and (54)(b)(XII) repealed, and (9.7), (15.5), (28.5), (35.5), (38.5)(a)(VII), (38.5)(a)(VIII), (39)(f), (39)(g), (39)(h), (39)(i), (39)(j), (39)(k), (46.5), (52.5), and (54)(b)(XVI) added, (SB 21-094), ch. 314, p. 1924, § 3, effective September 1.





Cross references: For the legislative declaration in HB 20-1216, see section 1 of chapter 190, Session Laws of Colorado 2020. For the legislative declaration in SB 20-136, see section 1 of chapter 70, Session Laws of Colorado 2020.

Structure Colorado Code